Samuels Eric R, Wang Tao
Analytical Sciences, Pharmaceutical Sciences, AbbVie Inc., 2525 Dupont Drive, Irvine, CA 92612, USA.
Analytical Sciences, Pharmaceutical Sciences, AbbVie Inc., 2525 Dupont Drive, Irvine, CA 92612, USA.
J Pharm Biomed Anal. 2022 May 10;213:114665. doi: 10.1016/j.jpba.2022.114665. Epub 2022 Feb 17.
Determination of impurity level in weight percent against the claimed active pharmaceutical ingredient (API) in a drug product is of critical importance in drug development. However, authentic material used to determine relative UV response factor (RRF) for impurity quantitation is sometimes not available or not stable. In a particular drug product liquid formulation, three degradants, including one unstable impurity, are consistently observed in stability studies. Here we describe the application of NMR spectroscopy to assist in the determination of RRFs, simultaneously, for all three degradants directly from degraded drug product extracts. This technique was not only effective in determining RRF of an unstable substance, but also in defining RRFs of multiple degradants from a single drug product sample. Overall, this study continues to demonstrate the capabilities of NMR for impurity quantitation in drug development.
在药品研发中,确定药品中杂质水平相对于所宣称的活性药物成分(API)的重量百分比至关重要。然而,用于确定杂质定量相对紫外响应因子(RRF)的正品材料有时无法获得或不稳定。在一种特定的液体制剂药品中,稳定性研究中持续观察到三种降解产物,包括一种不稳定杂质。在此,我们描述了核磁共振波谱法的应用,可直接从降解的药品提取物中同时协助确定所有三种降解产物的RRF。该技术不仅有效地确定了不稳定物质的RRF,还能从单一药品样品中确定多种降解产物的RRF。总体而言,本研究继续证明了核磁共振波谱法在药品研发中杂质定量方面的能力。